Company profile
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on manufacturing, developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company's product portfolio offers RYANODEX for malignant hyperthermia; and BELRAPZO and BENDEKA for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. It also produces PEMFEXY, a ready-to-dilute liquid form of pemetrexed injection,
- CEO
- Mr. Michael Graves
- Headquarters
- Woodcliff Lake, NJ, United States
- Employees
- 134
- IPO date
- Feb 12, 2014
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic